Affimed NV (AFMD)
5.42
+0.12
(+2.26%)
USD |
NASDAQ |
May 03, 16:00
5.47
+0.05
(+0.92%)
After-Hours: 20:00
Affimed Cash and Short Term Investments (Quarterly): 80.58M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 80.58M |
| September 30, 2023 | 103.18M |
| June 30, 2023 | 130.47M |
| March 31, 2023 | 169.94M |
| December 31, 2022 | 204.06M |
| September 30, 2022 | 219.08M |
| June 30, 2022 | 247.81M |
| March 31, 2022 | 189.57M |
| December 31, 2021 | 223.76M |
| September 30, 2021 | 230.52M |
| June 30, 2021 | 264.99M |
| March 31, 2021 | 282.14M |
| December 31, 2020 | 180.62M |
| September 30, 2020 | 114.29M |
| June 30, 2020 | 104.17M |
| March 31, 2020 | 97.32M |
| December 31, 2019 | 116.65M |
| September 30, 2019 | 83.73M |
| June 30, 2019 | 99.73M |
| March 31, 2019 | 106.83M |
| December 31, 2018 | 124.46M |
| Date | Value |
|---|---|
| September 30, 2018 | 43.08M |
| June 30, 2018 | 54.82M |
| March 31, 2018 | 68.23M |
| December 31, 2017 | 47.79M |
| September 30, 2017 | 49.26M |
| June 30, 2017 | 55.90M |
| March 31, 2017 | 57.37M |
| December 31, 2016 | 47.46M |
| September 30, 2016 | 55.12M |
| June 30, 2016 | 65.20M |
| March 31, 2016 | 75.65M |
| December 31, 2015 | 83.90M |
| September 30, 2015 | 67.99M |
| June 30, 2015 | 74.38M |
| March 31, 2015 | 40.10M |
| December 31, 2014 | 48.31M |
| September 30, 2014 | 57.79M |
| June 30, 2014 | 2.456M |
| March 31, 2014 | 6.937M |
| December 31, 2013 | 5.732M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
80.58M
Minimum
Dec 2023
282.14M
Maximum
Mar 2021
165.40M
Average
169.94M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| InflaRx NV | 99.79M |
| MorphoSys AG | 754.72M |
| BioNTech SE | 18.29B |
| Immatics NV | 470.78M |
| CureVac NV | 447.81M |